SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is actively trending as the community leans into its legacy as a 15-year-old parody of Bitcoin, with investors debating its long-term potential compared to serious financial assets. Discussion is largely fueled by the project's historical roots and a growing community narrative that frames the meme as an inevitable fixture in the crypto space.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is currently the subject of intense buyout speculation, fueled by the recent FDA grant of a landmark formal evidentiary hearing for its jet lag treatment and the approval of its bipolar medication, Bysanti. While investors are actively debating the impact of management's confrontational FDA strategy and price suppression, the community is closely monitoring the stock for potential acquisition by major pharmaceutical players looking to secure its high-value pipeline.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is drawing intense scrutiny as investors weigh its mixed earnings and cautious outlook against a backdrop of fierce EV competition and a recent recall involving battery safety. The community remains deeply polarized, with some traders betting on a turnaround fueled by the launch of the i6 and i8 models, while others are aggressively shorting the stock, pointing to slowing sales momentum and aggressive rivalry from competitors like Nio.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is currently capturing investor attention as traders debate whether its recent volatility and price compression create a prime entry point ahead of upcoming earnings. While some investors are concerned by consistent selling pressure and the stock's struggle to reclaim key resistance levels, others are highlighting the company's improved profitability, strong cash flow, and potential for an acquisition as catalysts that could drive a sharp recovery.

Maulcoin

Maulcoin is trending as investors rally behind a community-driven, organic growth strategy, actively pushing for a breakout while anticipating airdrops and chart visibility. The community is heavily focused on holding through volatility and maintaining strong diamond hands to drive the token toward higher market capitalization milestones.

Equinor ASA engages in the exploration, production, transport, refining, and marketing of petroleum and petroleum-derived products. It operates through the following segments: Exploration and Production Norway, Exploration and Production International, Exploration and Production USA, Marketing, Midstream, and Processing, Renewables, and Other. The Exploration and Production Norway segment includes the commercial development of oil and gas portfolios on the Norwegian continental shelf. The Exploration and Production International segment covers offshore and onshore activities in the USA, Mexico, and other operations worldwide. The Exploration and Production USA segment covers both onshore and offshore exploration, development, and Production of oil and gas in the USA. The Marketing, Midstream, and Processing segment markets and trades of crude oil and condensate, natural gas, NGL and refined products. The Renewables segment focuses on offshore wind, and integrated solutions for onshore renewables. The Other segment includes projects, drilling and procurement, the business area technology, digital and innovation, and corporate staffs and support functions. The company was founded on September 18, 1972 and is headquartered in Stavanger, Norway.

Equinor ASA - ADR

Equinor ASA

Equinor ASA is currently trending as investors monitor the company's role as a primary European energy supplier, with ongoing discussions focused on the impact of its North Sea infrastructure projects and natural gas distribution strategies. Market sentiment is bolstered by institutional activity surrounding dividend distributions and the company's long-term capital allocation plans, even as traders weigh the broader global energy landscape and supply-side pressures.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is attracting investor interest as a high-performance memory play, with the community highlighting its strategic role in DDR5 and CXL technologies amid ongoing data center demand. While participants debate the impact of recent supply chain issues and executive turnover, many remain bullish, viewing the company as an undervalued infrastructure provider that is well-positioned for future memory bandwidth shifts.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The Other segment includes DLP products, calculators, and custom application-specific integrated circuits products. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is currently trending as investors weigh mixed quarterly results against the company's cautious forward guidance, sparking a debate between those concerned about demand-side headwinds and those viewing the dip as a long-term entry point. The community is actively discussing the stock's role in industrial and automotive chip cycles, with some highlighting the stability of its dividend payouts as a key anchor amid the recent price volatility.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

The Vanguard Total Stock Market ETF is trending as investors debate the merit of broad market indexing versus tactical rotation strategies amid ongoing economic volatility and sector-specific concerns. Community discussions focus on the benefits of long-term capital accumulation through ETFs like VTI as a resilient hedge against market noise and speculative trading.

Meridian Holdings, Inc. engages in offering casino, sportsbook, and competition products. It operates through the following segments: MeridianBet Group, GMAG, and RKings and Classics For a Cause (CFAC). The MeridianBet Group segment includes revenues from retail sports betting, retail casinos, online sports betting, online casinos, and bars. The GMAG segment focuses on resale of third-party gaming content in the Asia-Pacific region. The RKings and CFAC segment includes revenues from pay-to-enter prize competitions and trade promotions, conducted through RKings in the UK and Classics in Australia. The company was founded by Weiting Feng and Anthony Brian Goodman in 2001 and is headquartered in Las Vegas, NV.

Meridian Holdings Inc.

Meridian Holdings is currently trending as investors debate a significant valuation gap and the impact of a large non-cash impairment charge on its recent earnings. The community is actively discussing the stock's growth trajectory and potential for a market rerating, while navigating concerns over low trading volume and persistent price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ritholtz Wealth Management Purchases 10,305 Shares of Merck & Co., Inc. $MRK

Ritholtz Wealth Management boosted its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 38.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange...

Massachusetts Financial Services Co. MA Sells 3,132,999 Shares of Merck & Co., Inc. $MRK

Massachusetts Financial Services Co. MA lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 41.5% during the 4th quarter, according to the company in its most recent...

Merck & Co., Inc. $MRK Shares Purchased by Choreo LLC

Choreo LLC boosted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund...

Carnegie Investment Counsel Grows Stock Position in Merck & Co., Inc. $MRK

Carnegie Investment Counsel raised its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 86,715 shares of the company's stock after buying an additional 11,849 shares during the period...

Prime Capital Investment Advisors LLC Sells 20,072 Shares of Merck & Co., Inc. $MRK

Prime Capital Investment Advisors LLC trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 37.1% during the fourth quarter, according to its most recent 13F filing with the...

Merck & Co., Inc. $MRK Position Lessened by Cantor Fitzgerald Investment Advisors L.P.

Cantor Fitzgerald Investment Advisors L.P. trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 21.5% in the 4th quarter, according to the company in its most recent Form...

Bartlett & CO. Wealth Management LLC Has $13.24 Million Position in Merck & Co., Inc. $MRK

Bartlett & CO. Wealth Management LLC trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 124,785 shares of the company's stock afte...

Bar Harbor Wealth Management Has $18.11 Million Stock Holdings in Merck & Co., Inc. $MRK

Bar Harbor Wealth Management increased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent filing with the...

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Terns Pharmaceuticals, Inc. (NasdaqGS: TERN) to...

BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock?

BMY stock jumps 10% in a month as growth drugs power revenues, but generic erosion and 2026 sales outlook keep investors cautious.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.48	--	--	N/A
Q4 '25	$2.01	$2.04	1.43%	BEAT
Q3 '25	$2.35	$2.58	9.90%	BEAT
Q2 '25	$2.02	$2.13	5.40%	BEAT
Q1 '25	$2.13	$2.22	3.99%	BEAT

MRK
Merck & Co Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest MRK News

MRKMerck & Co Inc